Tivic Health (Nasdaq:TIVC) CEO Jennifer Ernst issued a letter to investors updating them on the current situation at the bioelectronic medicine developer. Ernst’s letter included the announcement that the company took several measures to fortify its position. That includes a reduction in force and internal restructuring. The company did not disclose further details about the […]
Bioelectronic Medicine
NeuroOne prices $5.25M public offering
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering. Eden Prairie, Minnesota-based NeuroOne’s offering includes 5.25 million shares of common stock priced at $1 per share. All shares included in the offering will be sold by the company. NeuroOne also granted the underwriter a 30-day option to purchase up to […]
Medtronic neuromod vet joins miniature brain pacemaker developer Motif Neurotech as CTO
Minimally invasive bioelectronic maker Motif Neurotech announced today that it named Steven Goetz as its chief technology officer (CTO). Goetz joins after spending more than 26 years in the Neuromodulation unit at Medtronic. There, he led engineering and innovation initiatives for implantable device therapies for a wide range of diseases. Houston-based Motif Neurotech develops a […]
First patients treated in trial of Magnus Medical neurostim for depression
Magnus Medical announced today that it treated the first patients in the open-label optimization clinical trial for its Saint technology. The OLO trial evaluates the effectiveness of Saint technology for the treatment of major depressive disorder (MDD). The platform delivers individualized, rapid-acting, non-invasive neurostimulation. Saint treats adults who fail to achieve satisfactory improvement from prior antidepressant […]
Aetna policy update expands access to Neuronetics NeuroStar
Neuronetics (Nasdaq:STIM) announced today that a healthcare policy update from Aetna increases access to its NeuroStar therapy. Malvern, Pennsylvania-based Neuronetics develops products aimed at improving the life of patients with neuro health disorders. NeuroStar, a non-drug, non-invasive treatment can improve the quality of life for neuro health patients when traditional medication fails. The transcranial magnetic […]
Tivic Health prices $2.1M offering
Tivic Health (Nasdaq:TIVC) announced today that it priced its previously announced public offering of common stock at $2.1 million. News of this offering follows the pricing of a $1.8 million offering of common stock last week. San Francisco-based Tivic’s offer includes 51.25 million shares of common stock priced at 4¢ per share. The company expects […]
Boston Scientific wins FDA nod for image-guided programming software for deep brain stim
Boston Scientific announced today that the FDA approved its Vercise Neural Navigator 5 software. When used as part of the Vercise Genus deep brain stimulation (DBS) systems, the software offers clinicians simple, actionable data. It enables efficient programming in the treatment of people with Parkinson’s disease or essential tremor. Vercise Genus delivers targeted electrical stimulation […]
Tivic Health prices $1.8M common stock offering
Tivic Health Systems (Nasdaq:TIVC) announced today that it priced an offering of its common stock worth approximately $1.8 million. San Francisco-based Tivic priced the offering of 32.5 million shares of its common stock at $0.055 per share. The company intends to use the net proceeds for working capital and general corporate purposes. Tivic said it […]
Carthera closes $40M Series B to support SonoCloud
Carthera announced today that it closed a $40 million Series B financing round to support its ultrasound-based SonoCloud device. Paris-based Carthera, a spinoff from Sorbonne University, develops SonoCloud to treat a wide range of brain disorders. SonoCloud emits ultrasound to temporarily increase the permeability of blood vessels in the brain, improving therapeutic molecule delivery. After […]
Cala Health, Cue Health have layoffs in California
Cala Health and Cue Health (Nasdaq:HLTH) both recently filed with the state of California to confirm reductions in their workforces. The two companies are the latest to join the long list of medtech companies cutting employees amid a challenging time for the industry. To date, MassDevice has reported on more than 18,000 medtech employees who have been […]
Sooma wins FDA breakthrough nod for neuromod that treats depression
Sooma Medical today announced that it received FDA breakthrough device designation for its neuromodulation device for treating depression. The portable, patient-administered neuromodulation device utilizes a mild electrical current. It stimulates targeted brain areas resulting in a significant improvement in depressive symptoms. “We are thrilled to receive this breakthrough designation from the FDA,” said Tuomas Neuvonen, […]